Sonothrombolysis Augments Reperfusion in ST-Elevation Myocardial Infarction With Primary Percutaneous Coronary...

Area of Science:

• Cardiology
• Medical Imaging
• Interventional Cardiology

Background:

• Reperfusion injury is a significant complication after primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI).
• Effective reperfusion is crucial for limiting infarct size and preserving left ventricular function.

Purpose of the Study:

• To evaluate the feasibility and efficacy of sonothrombolysis, utilizing myocardial contrast echocardiography with high mechanical index ultrasound impulses, initiated prior to primary PCI in STEMI patients.
• To assess the impact of this novel technique on pre-PCI and post-reperfusion flow, ST-segment resolution, and 90-day left ventricular ejection fraction.

Main Methods:

• A prospective, single-arm study conducted in Canada involving 15 STEMI patients.
• Sonothrombolysis was administered using myocardial contrast echocardiography with high mechanical index ultrasound impulses before primary PCI.
• Thrombolysis In Myocardial Infarction (TIMI) flow, ST-segment resolution, and left ventricular ejection fraction (LVEF) were assessed.

Main Results:

• Sonothrombolysis resulted in TIMI-2/3 flow in 7 patients (46.7%) prior to PCI.
• All 15 patients achieved TIMI-3 flow post-reperfusion, and 14 (93.3%) showed ST-segment resolution ≥ 50% at 30 minutes post-PCI.
• At 90 days, 12 patients (80.0%) had a normal LVEF (≥ 50%).

Conclusions:

• The study demonstrates the feasibility of sonothrombolysis as a novel technique to enhance reperfusion in STEMI patients undergoing primary PCI.
• The findings support the potential of this approach to improve myocardial salvage and cardiac function recovery.
• A randomized Canadian study is warranted to further validate these promising results.